{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T20:08:30Z","timestamp":1772136510542,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,16]],"date-time":"2025-02-16T00:00:00Z","timestamp":1739664000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,16]],"date-time":"2025-02-16T00:00:00Z","timestamp":1739664000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-90444-y","type":"journal-article","created":{"date-parts":[[2025,2,16]],"date-time":"2025-02-16T04:01:01Z","timestamp":1739678461000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Machine learning-based identification of co-expressed genes in prostate cancer and CRPC and construction of prognostic models"],"prefix":"10.1038","volume":"15","author":[{"given":"Changhui","family":"Fan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianhe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junfeng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changbao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changhui","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,16]]},"reference":[{"key":"90444_CR1","doi-asserted-by":"publisher","unstructured":"Global burden of disease cancer collaboration, Fitzmaurice C, Akinyemiju TF, et al. 2018 Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016: A Systematic Analysis for the Global Burden of Disease Study. JAMA oncology, 4(11):1553\u20131568. https:\/\/doi.org\/10.1001\/jamaoncol.2018.2706 (2018).","DOI":"10.1001\/jamaoncol.2018.2706"},{"issue":"2","key":"90444_CR2","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1001\/jama.2019.20675","volume":"323","author":"KE Hoffman","year":"2020","unstructured":"Hoffman, K. E. et al. Patient-reported outcomes through 5 years for active surveillance, surgery, brachytherapy, or external beam radiation with or without androgen deprivation therapy for localized prostate cancer. JAMA 323(2), 149\u2013163. https:\/\/doi.org\/10.1001\/jama.2019.20675 (2020).","journal-title":"JAMA"},{"issue":"12","key":"90444_CR3","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/nrc4016","volume":"15","author":"PA Watson","year":"2015","unstructured":"Watson, P. A., Arora, V. K. & Sawyers, C. L. Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer. Nat. Rev. Cancer 15(12), 701\u2013711. https:\/\/doi.org\/10.1038\/nrc4016 (2015).","journal-title":"Nat. Rev. Cancer"},{"issue":"16","key":"90444_CR4","doi-asserted-by":"publisher","first-page":"3967","DOI":"10.3390\/cancers13163967","volume":"13","author":"M El Fakiri","year":"2021","unstructured":"El Fakiri, M. et al. PSMA-Targeting radiopharmaceuticals for prostate cancer therapy: Recent developments and future perspectives. Cancers 13(16), 3967. https:\/\/doi.org\/10.3390\/cancers13163967 (2021).","journal-title":"Cancers"},{"issue":"7406","key":"90444_CR5","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/nature11125","volume":"487","author":"CS Grasso","year":"2012","unstructured":"Grasso, C. S. et al. The mutational landscape of lethal castration-resistant prostate cancer. Nature 487(7406), 239\u2013243. https:\/\/doi.org\/10.1038\/nature11125 (2012).","journal-title":"Nature"},{"issue":"20","key":"90444_CR6","doi-asserted-by":"publisher","first-page":"4698","DOI":"10.1158\/1078-0432.CCR-15-0157","volume":"21","author":"X Zhang","year":"2015","unstructured":"Zhang, X. et al. SRRM4 Expression and the loss of rest activity may promote the emergence of the neuroendocrine phenotype in castration-resistant prostate cancer. Clin. Canc. Res.: An Off. J. Am. Assoc. Canc. Res. 21(20), 4698\u20134708. https:\/\/doi.org\/10.1158\/1078-0432.CCR-15-0157 (2015).","journal-title":"Clin. Canc. Res.: An Off. J. Am. Assoc. Canc. Res."},{"key":"90444_CR7","unstructured":"Limma powers differential expression analyses for RNA-sequencing and microarray studies - PubMed[EB\/OL]. [2024\u201302\u201325]. https:\/\/pubmed.ncbi.nlm.nih.gov\/25605792\/."},{"issue":"5","key":"90444_CR8","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu, G. et al. clusterProfiler: An R package for comparing biological themes among gene clusters. Omics: J. Integr. Biol., 16(5), 284\u2013287. https:\/\/doi.org\/10.1089\/omi.2011.0118 (2012).","journal-title":"Omics: J. Integr. Biol.,"},{"issue":"1","key":"90444_CR9","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/bimj.200900028","volume":"52","author":"JJ Goeman","year":"2010","unstructured":"Goeman, J. J. L1 penalized estimation in the Cox proportional hazards model. Biometr. J. Biometr. Zeitschrift 52(1), 70\u201384. https:\/\/doi.org\/10.1002\/bimj.200900028 (2010).","journal-title":"Biometr. J. Biometr. Zeitschrift"},{"key":"90444_CR10","unstructured":"Comprehensive investigation of a novel differentially expressed lncRNA expression profile signature to assess the survival of patients with colorectal adenocarcinoma - PubMed[EB\/OL]. [2024-02-25]. https:\/\/pubmed.ncbi.nlm.nih.gov\/28187432\/."},{"key":"90444_CR11","unstructured":"A nonparametric test for the association between longitudinal covariates and censored survival data - PubMed[EB\/OL]. [2024-02-25]. https:\/\/pubmed.ncbi.nlm.nih.gov\/30796830\/."},{"issue":"1","key":"90444_CR12","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1093\/annonc\/mdx637","volume":"29","author":"S Jain","year":"2018","unstructured":"Jain, S. et al. Validation of a Metastatic Assay using biopsies to improve risk stratification in patients with prostate cancer treated with radical radiation therapy. Ann. Oncol.: Off. J. Eur. Soci. Med. Oncol. 29(1), 215\u2013222. https:\/\/doi.org\/10.1093\/annonc\/mdx637 (2018).","journal-title":"Ann. Oncol.: Off. J. Eur. Soci. Med. Oncol."},{"issue":"1","key":"90444_CR13","first-page":"8663","volume":"24","author":"TN Showalter","year":"2017","unstructured":"Showalter, T. N. Commentary: In search of answers regarding the benefits and harms of short term ADT for intermediate-risk prostate cancer. The Canad. J. Urol. 24(1), 8663 (2017).","journal-title":"The Canad. J. Urol."},{"issue":"3","key":"90444_CR14","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s11523-020-00720-2","volume":"15","author":"S Chowdhury","year":"2020","unstructured":"Chowdhury, S. et al. Real-world outcomes in first-line treatment of metastatic castration-resistant prostate cancer: The prostate cancer registry. Targeted Oncol. 15(3), 301\u2013315. https:\/\/doi.org\/10.1007\/s11523-020-00720-2 (2020).","journal-title":"Targeted Oncol."},{"issue":"23","key":"90444_CR15","doi-asserted-by":"publisher","first-page":"5523","DOI":"10.3390\/cancers15235523","volume":"15","author":"YJ Kahm","year":"2023","unstructured":"Kahm, Y. J. et al. Impact of KIF4A on cancer stem cells and EMT in lung cancer and Glioma. Cancers 15(23), 5523. https:\/\/doi.org\/10.3390\/cancers15235523 (2023).","journal-title":"Cancers"},{"issue":"3","key":"90444_CR16","doi-asserted-by":"publisher","first-page":"49","DOI":"10.25011\/cim.v43i3.34393","volume":"43","author":"J Chen","year":"2020","unstructured":"Chen, J. et al. KIF4A: A potential biomarker for prediction and prognostic of prostate cancer. Clin. Invest. Med. 43(3), 49\u201359. https:\/\/doi.org\/10.25011\/cim.v43i3.34393 (2020).","journal-title":"Clin. Invest. Med."},{"issue":"1","key":"90444_CR17","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1186\/s40001-023-01575-9","volume":"28","author":"KH Ong","year":"2023","unstructured":"Ong, K. H. et al. Ubiquitin-conjugating enzyme E2C (UBE2C) is a prognostic indicator for cholangiocarcinoma. Eur. J. Med. Res. 28(1), 593. https:\/\/doi.org\/10.1186\/s40001-023-01575-9 (2023).","journal-title":"Eur. J. Med. Res."},{"issue":"3","key":"90444_CR18","doi-asserted-by":"publisher","first-page":"774","DOI":"10.3324\/haematol.2019.222133","volume":"105","author":"F Chatonnet","year":"2020","unstructured":"Chatonnet, F. et al. The hydroxymethylome of multiple myeloma identifies FAM72D as a 1q21 marker linked to proliferation. Haematologica 105(3), 774\u2013783. https:\/\/doi.org\/10.3324\/haematol.2019.222133 (2020).","journal-title":"Haematologica"},{"key":"90444_CR19","doi-asserted-by":"crossref","unstructured":"S R D, E T, S D, et al. LIX1 Controls MAPK Signaling Reactivation and Contributes to GIST-T1 Cell Resistance to Imatinib. Int. journal of molecular sciences, 2023, 24(8)[2024\u201302\u201325]. https:\/\/pubmed.ncbi.nlm.nih.gov\/37108337\/.","DOI":"10.3390\/ijms24087138"},{"key":"90444_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/mc.23679","author":"J Li","year":"2024","unstructured":"Li, J. et al. BST2 promotes gastric cancer metastasis under the regulation of HOXD9 and PABPC1. Mol. Carcinogen. https:\/\/doi.org\/10.1002\/mc.23679 (2024).","journal-title":"Mol. Carcinogen."},{"issue":"1","key":"90444_CR21","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1186\/s12957-023-03240-1","volume":"21","author":"Y Yang","year":"2023","unstructured":"Yang, Y. et al. Role of hypermethylated SLC5A8 in follicular thyroid cancer diagnosis and prognosis prediction. World J. Surg. Oncol. 21(1), 367. https:\/\/doi.org\/10.1186\/s12957-023-03240-1 (2023).","journal-title":"World J. Surg. Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-90444-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-90444-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-90444-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,16]],"date-time":"2025-02-16T04:01:04Z","timestamp":1739678464000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-90444-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,16]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["90444"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-90444-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4203768\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,16]]},"assertion":[{"value":"2 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5679"}}